鲁南制药集团营销渠道变革策略研究
[Abstract]:With the acceleration of the marketization of the pharmaceutical industry, the continuous implementation of the medical reform policy, pharmaceutical enterprises increasingly fierce competition, with the advantage of marketing channels is one of the effective ways to obtain lasting competitiveness. Under this background, the marketing channel reform of Lunan Pharmaceutical Group is deeply analyzed. The thesis synthetically uses the literature review, the theory unifies the practice research method. First of all, summarize the domestic and foreign marketing channel academic research situation, clear the main research theory of the marketing channel between China and the west. Secondly, the relevant theories of marketing, marketing channels and pharmaceutical marketing channels are expounded in this paper, which lays a theoretical foundation for the research. Then it analyzes the basic situation and development trend of the pharmaceutical marketing channel in China, finds out the common problems, and analyzes the influence of the new medical reform policy on the pharmaceutical marketing channel. The marketing environment of Lunan Pharmaceutical Group is analyzed by PEST analysis and five-force model method. This paper summarizes the two existing marketing channel models of Lunan Pharmaceutical Group, quantitatively analyzes the two channels from the aspects of sales ability and comprehensive measurement of performance, and studies the problems existing in the existing marketing channels: the lack of scientific channel mode selection, and the lack of channel management. The design of channel structure is unreasonable. According to certain optimization principles, this paper optimizes the marketing channel of Lunan Pharmaceutical Group. According to the actual situation, it puts forward the optimization scheme, that is, on the basis of the original channel, two channels system, social channel and own channel, are established. Use innovative methods to implement different marketing channel programs in different regions. Finally, the paper summarizes the research conclusions, and puts forward the research prospects for the further problems such as channel management, channel information and electronic channel innovation after the change. The paper holds that the Lunan Pharmaceutical Group can improve the management efficiency, expand the market coverage rate, have more advantages in the competition of pharmaceutical enterprises, and realize the strategic development of the enterprises under the impetus of the new channel.
【学位授予单位】:天津大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:F274;F426.72
【相似文献】
相关期刊论文 前5条
1 闫鑫;杜永武;;鲁南制药集团:争做环境保护的模范[J];中国环境管理;2010年04期
2 张木楠;车斌;;创业创新 税收同行——鲁南制药集团的发展之路[J];中国税务;2012年05期
3 闫鑫;杨柳;;全国人大代表、鲁南制药集团董事长赵志全呼吁 药品召回机制亟待建立[J];中国质量与品牌;2006年03期
4 阎鑫;;保护知识产权是企业兴旺发达的前提[J];中国审判;2008年03期
5 ;[J];;年期
相关重要报纸文章 前10条
1 张子成 闫鑫 杜永武 张铭锌;鲁南制药集团:科技创新铸辉煌[N];经济参考报;2012年
2 熊峰邋通讯员 闫鑫;鲁南制药集团再获“国家科技进步奖”[N];消费日报;2008年
3 闫鑫;鲁南制药集团:革命老区的创新旗帜[N];消费日报;2008年
4 闫鑫;鲁南制药集团荣获中国驰名商标[N];科技日报;2006年
5 闫鑫邋杜永武;鲁南制药集团致富思源回报社会[N];消费日报;2007年
6 闫鑫 张子成 杜永武;沐科学发展春风创企业成就辉煌[N];经济参考报;2013年
7 中央党校报刊社调研组 余昌淼 吴辉 郝凤明 闫鑫 (执笔人 吴辉);创新发展 科学发展 和谐发展[N];学习时报;2013年
8 鲁南制药集团股份有限公司党委书记 董事长 赵志全;善学者顺势兴[N];学习时报;2013年
9 本报记者 于进 通讯员 闫鑫;“减”出来的发展增量[N];中国经济导报;2009年
10 通讯员 闫鑫 本报记者 杜文;醋酸回收新工艺实现节能减排[N];中国企业报;2008年
相关硕士学位论文 前1条
1 牛桂云;鲁南制药集团营销渠道变革策略研究[D];天津大学;2014年
本文编号:2273826
本文链接:https://www.wllwen.com/jingjilunwen/gongyejingjilunwen/2273826.html